If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
114.00    3.50 (3.17%)
Bid:
109.00
Ask:
110.00
Spread: 1.00 (0.917%)
Market Cap: £112.35m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Trading Update

11 Dec 2019 07:00

RNS Number : 4378W
Eurocell plc
11 December 2019
 

11 December 2019

 

EUROCELL PLC

(Symbol: ECEL)

 

Trading Update

 

Eurocell(1) provides this update for the 11 months to 30 November 2019.

 

Trading and Operational Performance

We have continued to take market share and deliver a good sales performance in the second half of the year, albeit against strong 2018 comparatives. Revenue for the 11 months to 30 November 2019 is up 7% on a like-for-like basis(2).

·; Profiles division - like-for-like growth of 5% includes good contributions from both existing and new accounts from across our fabricator base.

·; Building Plastics - like-for-like growth of 8% reflects the positive impact of better stock availability and our new management team driving improvements in operating standards.

 

Gross margin is ahead of last year, reflecting higher usage of recycled material and selling price increases implemented progressively across the business in the first half to recover cost inflation.

 

We continue to incur some operating inefficiencies. However, as previously announced, Mark Hemming joined the business as Chief Operating Officer in August. Mark has made an excellent start and is now leading our drive to improve operating efficiency, focused initially in the following areas:

·; The capex programme launched at the beginning of the year to improve manufacturing efficiency and increase co-extrusion and foam capacity by 30% and 15% respectively is now complete. All the new lines are fully operational and working well.

·; As described at the half year, we have suffered some delays with our project to expand recycling capacity at Ecoplas. However, the programme is now well advanced and performance is improving.

·; We have continued to incur additional warehousing and distribution costs, particularly through the peak period, including the impact of a change in transport provider in September when the previous contract expired. We are reviewing options to expand our warehousing capacity.

 

As previously reported, we have invested in a stock build programme to mitigate the possible impact of raw material supply interruption due to Brexit, and to increase stock holding at our branches. We have added approximately £5 million to finished goods for key product lines under the plan, which provides a good level of protection and much improved availability.

 

Taken together, these factors underpin our current expectations for full year earnings.

 

Notice of Results

We will announce our preliminary results for the year ending 31 December 2019 on 13 March 2020.

 

 

~~~~~~~~~~~~~~~~~~~~~~~

 

 

Notes:

(1) Eurocell plc is a market leading, vertically integrated UK manufacturer, recycler and distributor of innovative window, door and roofline PVC products.

(2) Like-for-like sales exclude acquisitions and branches opened in 2018/19.

 

 

Enquiries:

Eurocell plc

Mark Kelly, Chief Executive Officer

+44 (0) 1773 842 105

 

Michael Scott, Chief Financial Officer

+44 (0) 1773 842 140

 

Teneo

Ben Foster

+44 (0) 20 3603 5221

 

Camilla Cunningham

+44 (0) 20 3757 9235

 

eurocell@teneo.com

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKMMMZFGGGLZZ
Date   Source Headline
2nd Aug 20217:00 amRNSTotal Voting Rights
20th Jul 20217:00 amRNSTrading Update
1st Jul 20217:00 amRNSTotal Voting Rights
1st Jun 20217:00 amRNSTotal Voting Rights
14th May 202111:18 amRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Update – Strong First Four Months
12th May 20216:13 pmRNSDirector/PDMR Shareholding
4th May 20217:00 amRNSTotal Voting Rights
26th Apr 20219:40 amRNSDirector/PDMR Shareholding
20th Apr 20217:00 amRNSBlock Listing Application
16th Apr 20211:10 pmRNSAnnual Financial Report
16th Mar 20211:39 pmRNSInvestor Presentation
12th Mar 20217:00 amRNSFinal Results
10th Mar 20217:00 amRNSBlock listing Interim Review
22nd Feb 202112:02 pmRNSNotice of Full Year Results Announcement
15th Jan 20217:00 amRNSYear End Trading Update – Strong Finish to 2020
12th Jan 20219:06 amRNSHolding(s) in Company
4th Jan 20217:00 amRNSTotal Voting Rights
1st Dec 20207:00 amRNSTotal Voting Rights
27th Nov 20207:00 amRNSDirector/PDMR Shareholding
19th Nov 20203:00 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSInvestor Presentation
17th Nov 20207:00 amRNSTrading Update – Improved Outlook
2nd Nov 20207:00 amRNSTotal Voting Rights
27th Oct 202011:23 amRNSHolding(s) in Company
15th Oct 202012:30 pmRNSDirector/PDMR Shareholding
1st Oct 20207:00 amRNSTotal Voting Rights
16th Sep 202012:20 pmRNSDirector/PDMR Shareholding
11th Sep 20207:00 amRNSDirector/PDMR Shareholding
7th Sep 202010:37 amRNSBlock listing Interim Review
4th Sep 20207:00 amRNSResults for the six months ended 30 June 2020
2nd Sep 20209:59 amRNSHolding(s) in Company
1st Sep 20207:00 amRNSTotal Voting Rights
27th Aug 20209:59 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSTotal Voting Rights
8th Jul 20207:00 amRNSCOVID-19 and Trading Update
1st Jul 20209:34 amRNSTotal Voting Rights
30th Jun 20204:53 pmRNSNotice of Results
4th Jun 202011:47 amRNSDirector Declaration
26th May 20209:37 amRNSBlock Listing Application
19th May 20208:46 amRNSResult of AGM - Correction
15th May 202011:34 amRNSResult of AGM
14th May 20207:00 amRNSAGM and COVID-19 Update
30th Apr 20205:09 pmRNSHolding(s) in Company
17th Apr 202012:55 pmRNSAnnual Financial Report
16th Apr 20205:02 pmRNSHolding(s) in Company
14th Apr 20202:52 pmRNSDirector/PDMR Shareholding
7th Apr 20202:14 pmRNSHolding(s) in Company
3rd Apr 202012:13 pmRNSHolding(s) in Company
1st Apr 20203:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.